NCT00958984 is a clinical trial in Pediatric Solid Organ Transplant, sponsored by University of Nebraska.

Who is sponsoring NCT00958984?

NCT00958984 is sponsored by University of Nebraska.

What condition does NCT00958984 study?

NCT00958984 studies Pediatric Solid Organ Transplant.

Is NCT00958984 still recruiting?

NCT00958984 is currently completed. Last updated 6 September 2023.

Last reviewed 2023-09-06 · How we verify

NCT00958984

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continuous Hemoglobin Monitoring in Pediatric Transplant

Completed Last updated 6 September 2023

What this trial tests

trial in Pediatric Solid Organ Transplant in 21 participants. Completed in 1 November 2011.

Timeline

11 August 2009

Primary endpoint
1 August 2011

1 November 2011

Quick facts

Lead sponsor	University of Nebraska
Status	Completed
Study type	OBSERVATIONAL
Enrollment	21
Start date	11 August 2009
Primary completion	1 August 2011
Estimated completion	1 November 2011
Sites	1 location across United States

Conditions studied

Pediatric Solid Organ Transplant — all drugs for Pediatric Solid Organ Transplant →

Sponsor

University of Nebraska

Who can join

Under 18, any sex, with Pediatric Solid Organ Transplant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the clinical utility of non-invasive monitoring of Hemoglobin (Hgb) and Plethysmograph Variability Index (PVI) values during the intraoperative period of visceral solid organ transplantation in children. Hemoglobin values reflect oxygen-carrying capacity of the blood and PVI reflects fluid balance and perfusion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Nebraska trials

Trials by the same sponsor.

NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00958984 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
Last refreshed: 6 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00958984.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing